<bill session="116" type="s" number="660" updated="2019-04-16T04:42:19Z">
  <state datetime="2019-03-05">REFERRED</state>
  <status>
    <introduced datetime="2019-03-05"/>
  </status>
  <introduced datetime="2019-03-05"/>
  <titles>
    <title type="official" as="introduced">A bill to address abuse of the Food and Drug Administration's citizen petition process by brand drug manufacturers.</title>
    <title type="short" as="introduced">Efficiency and Transparency in Petitions Act</title>
    <title type="short" as="introduced">Efficiency and Transparency in Petitions Act</title>
    <title type="display">Efficiency and Transparency in Petitions Act</title>
  </titles>
  <sponsor bioguide_id="B001310"/>
  <cosponsors/>
  <actions>
    <action datetime="2019-03-05">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-03-05" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative remedies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
